Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000707735 | SCV000836845 | benign | Bethlem myopathy 1A | 2023-10-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001759424 | SCV001988191 | uncertain significance | not provided | 2021-04-28 | criteria provided, single submitter | clinical testing | Previously reported as a variant of uncertain significance in an individual with a clinical diagnosis of LGMD; variants in other genes that may influence the phenotype were also obsevered (Fichna et al., 2018); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29970176) |
Revvity Omics, |
RCV001759424 | SCV003834582 | uncertain significance | not provided | 2019-08-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004547879 | SCV004115750 | uncertain significance | COL6A3-related disorder | 2024-02-15 | no assertion criteria provided | clinical testing | The COL6A3 c.7192G>A variant is predicted to result in the amino acid substitution p.Val2398Ile. This variant has been previously reported in the compound heterozygous state in an individual with limb-girdle muscular dystrophy (Table 1, Fichna et al. 2018. PubMed ID: 29970176). This variant is reported in 0.026% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |